HC Wainwright Weighs in on Cibus’ Q1 Earnings (NASDAQ:CBUS)

Cibus, Inc. (NASDAQ:CBUS) – HC Wainwright issued their Q1 2025 earnings estimates for shares of Cibus in a report released on Friday, March 21st. HC Wainwright analyst A. Dayal expects that the company will earn ($0.66) per share for the quarter. HC Wainwright currently has a “Buy” rating and a $25.00 target price on the stock. The consensus estimate for Cibus’ current full-year earnings is ($2.96) per share. HC Wainwright also issued estimates for Cibus’ Q2 2025 earnings at ($0.67) EPS, Q3 2025 earnings at ($0.69) EPS, Q4 2025 earnings at ($0.70) EPS and FY2029 earnings at $1.36 EPS.

Cibus (NASDAQ:CBUS) last released its quarterly earnings data on Thursday, March 20th. The company reported ($0.87) EPS for the quarter, missing the consensus estimate of ($0.68) by ($0.19). Cibus had a negative return on equity of 28.17% and a negative net margin of 10,724.78%. The company had revenue of $1.21 million during the quarter, compared to analysts’ expectations of $1.13 million.

Separately, Canaccord Genuity Group lowered their price target on shares of Cibus from $20.00 to $18.00 and set a “buy” rating for the company in a report on Wednesday, January 22nd.

Cibus Stock Performance

NASDAQ:CBUS opened at $2.20 on Monday. Cibus has a fifty-two week low of $1.80 and a fifty-two week high of $23.18. The firm has a market cap of $58.20 million, a PE ratio of -0.10 and a beta of 2.04. The business has a 50 day moving average price of $2.33 and a 200-day moving average price of $3.30.

Institutional Investors Weigh In On Cibus

Institutional investors and hedge funds have recently bought and sold shares of the business. FMR LLC raised its holdings in shares of Cibus by 16.9% during the third quarter. FMR LLC now owns 3,913,279 shares of the company’s stock valued at $12,757,000 after acquiring an additional 566,328 shares in the last quarter. Wellington Management Group LLP purchased a new position in Cibus during the 3rd quarter valued at $111,000. Charles Schwab Investment Management Inc. raised its holdings in Cibus by 14.6% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 49,285 shares of the company’s stock worth $161,000 after purchasing an additional 6,276 shares in the last quarter. IFP Advisors Inc bought a new position in Cibus in the 4th quarter worth $36,000. Finally, State Street Corp lifted its position in shares of Cibus by 43.6% in the 3rd quarter. State Street Corp now owns 307,262 shares of the company’s stock worth $1,002,000 after purchasing an additional 93,236 shares during the period. Hedge funds and other institutional investors own 33.81% of the company’s stock.

Cibus Company Profile

Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.